ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Sudarshan Pharma Industries Ltd reported revenue from operations of ₹174.4 Cr (+20.0% YoY) and net profit of ₹5.6 Cr (+40.0% YoY) for Q1 FY27.
Sudarshan Pharma Industries Ltd reported revenue from operations of ₹220.9 Cr (+36.7% YoY) and net profit of ₹11.4 Cr (+54.1% YoY) for Q4 FY26.
Sudarshan Pharma Industries Ltd reported consolidated total income of ₹711.77 Crore for the financial year ended March 31, 2026. Consolidated net profit reached ₹23.30 Crore, up from ₹14.97 Crore in the previous year. The company successfully transitioned to Ind AS reporting during the period, reflecting strong operational growth and expanded financial transparency.
Sudarshan Pharma Industries Ltd reported net profit of ₹4.1 Cr (+41.4% YoY) for Q3 FY26.